Literature DB >> 18432796

Delayed-type hypersensitivity.

Y Luo1, M E Dorf.   

Abstract

Delayed-type hypersensitivity (DTH) is an in vivo assay of cell-mediated immune function. DTH reactions are often divided into two phases: the sensitization phase, referring to the initial immunization with specific antigen, and the efferent or challenge phase of the DTH response, which usually follows 6 to 14 days after sensitization. This unit details the protocol for stimulating DTH responses in mice to the O-succinimide ester of the hapten 4-hydroxy-3-nitrophenyl acetyl (abbreviated NP-O-Su).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 18432796     DOI: 10.1002/0471142735.im0405s55

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  4 in total

1.  CD8+ T cells produce a dialyzable antigen-specific activator of dendritic cells.

Authors:  Ian A Myles; Ming Zhao; Glenn Nardone; Lisa R Olano; Jensen D Reckhow; Danial Saleem; Timothy J Break; Michail S Lionakis; Timothy G Myers; Paul J Gardina; Charles H Kirkpatrick; Steven M Holland; Sandip K Datta
Journal:  J Leukoc Biol       Date:  2016-08-11       Impact factor: 4.962

2.  Evaluation of the Induction of Cell-Mediated Immunity Against Candida albicans in a Model of Cutaneous Infection in Newborn 0-Day-Old Mice.

Authors:  O E Flores-Maldonado; A M Montoya; A Andrade; G M González; S A Aguilar-Fernández; M Elizondo-Zertuche; R Chacón-Salinas; H Rocha-Rodríguez; M A Becerril-García
Journal:  Mycopathologia       Date:  2019-10-21       Impact factor: 2.574

3.  Suppression of autoimmune demyelinating disease by preferential stimulation of CNS-specific CD8 T cells using Listeria-encoded neuroantigen.

Authors:  Farah R Itani; Sushmita Sinha; Ashley A Brate; Lecia L Pewe; Katherine N Gibson-Corley; John T Harty; Nitin J Karandikar
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

4.  Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.

Authors:  Mosayeb Rostamian; Fariborz Bahrami; Hamid M Niknam
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.